Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

This study is currently recruiting participants.

Study NCT00073983 Information provided by National Cancer Institute (NCI)

First Received: December 10, 2003 Last Updated: July 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)